Related Experiment Video
Updated: Jan 30, 2026

A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells
Published on: March 28, 2021
An Integrated Stress Response Agent that Modulates DR5-Dependent TRAIL Synergy Reduces Patient-Derived Glioma Stem
Saad Sheikh1, Deeksha Saxena2, Xiaobing Tian3
1Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. JayD@uphs.upenn.edu saad.sheikh@uphs.upenn.edu.
Abstract:
The high incidence of glioblastoma recurrence necessitates additional therapeutic strategies. Heterogeneous populations of cells, including glioma stem cells (GSC) have been implicated in disease recurrence. GSCs are able to survive irradiation and temozolomide (TMZ) treatment due to upregulation of DNA damage pathways. One potential strategy to target treatment-resistant tumor populations may be via the integrated stress response (ISR). Modulation of the ISR pathway also allows for sensitization of treatment-resistant cells to TRAIL. We generated a novel cell-based death receptor assay to identify potent inducers of ISR-dependent DR5 expression. We used this assay to screen compounds from three commercially available libraries, and identified 1-benzyl-3-cetyl-2-methylimidazolium iodide (NH125) as a potent inducer of DR5 expression. NH125 engages the EIF2α-ATF4-CHOP axis culminating in DR5 expression at low micromolar doses. Expression of CHOP plays a critical role in NH125-mediated TRAIL synergy. Treatment of GSC with NH125 produces a marked reduction in viability when compared with other cell lines. NH125-treated GSC also synergize with lower doses of TRAIL when compared with all other cell lines tested. Transcriptional analysis of NH125-treated GSC uncovers a unique profile that involves activation of ISR and GADD45 pathways. Treatment of GSC xenografts with encapsulated PEG-PCL-NH125 leads to a sustained decrease in tumor volume. IMPLICATIONS: Taken together, these data suggest that engaging the ISR pathway represents a promising strategy to target treatment refractory GSC that have been implicated in glioblastoma recurrence.
Insights
Targeting the integrated stress response (ISR) pathway with NH125 shows promise for glioblastoma recurrence. This compound sensitizes glioma stem cells (GSC) to TRAIL therapy, reducing tumor volume in vivo.
Area of Science:
- Oncology
- Molecular Biology
- Drug Discovery
Background:
- Glioblastoma recurrence is common, driven by treatment-resistant glioma stem cells (GSC).
- GSCs survive therapies like irradiation and temozolomide (TMZ) by activating DNA damage pathways.
- The integrated stress response (ISR) pathway offers a potential target to overcome treatment resistance.
Purpose of the Study:
- To identify novel compounds that induce ISR-dependent death receptor 5 (DR5) expression.
- To evaluate the efficacy of identified compounds in sensitizing GSCs to TRAIL therapy.
- To assess the therapeutic potential of NH125 in preclinical glioblastoma models.
Main Methods:
- Development of a cell-based assay to screen for ISR-dependent DR5 inducers.
- Screening of commercial compound libraries to identify potent DR5 inducers.
- In vitro and in vivo studies using GSCs, glioblastoma cell lines, and xenografts.
Main Results:
- NH125 was identified as a potent inducer of DR5 expression via the EIF2α-ATF4-CHOP axis.
- NH125 significantly reduced GSC viability and synergized with TRAIL at lower doses.
- Encapsulated NH125 in PEG-PCL nanoparticles decreased glioblastoma xenograft tumor volume.
Conclusions:
- Modulating the ISR pathway is a promising strategy to target treatment-refractory GSCs.
- NH125 demonstrates potential as a therapeutic agent for glioblastoma by targeting GSCs.
- NH125 combined with TRAIL offers a synergistic approach to combat glioblastoma recurrence.
Related Concept Videos
Responses to Salt Stress
Responses to Heat and Cold Stress
The Integrated Rate Law: The Dependence of Concentration on Time
Stress Response System
Alarm stage
In the alarm stage, the body's...
Redox Titration: Other Oxidizing and Reducing Agents
Psychological Responses to Stress

